Literature DB >> 14611929

Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.

George Garyfallos1, Dimos Dimelis, Philippos Kouniakis, Nikos Sidiropoulos, Anastasia Karastergiou, Grigoris Lavrentiadis, John Giouzepas, Kostas Fokas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14611929     DOI： 10.1016/j.eurpsy.2003.06.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN： 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  4 in total

1.  Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study.

Authors:  Praveen Rikhari; Ashutosh Kumar; Prabhat Agrawal; Harendra Kumar
Journal:  J Family Med Prim Care       Date:  2022-05-14

2.  Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.

Authors:  Haya Ascher-Svanum; Michael Stensland; Zhongyun Zhao; Bruce J Kinon
Journal:  BMC Psychiatry       Date:  2005-01-13       Impact factor: 3.630

Review 3.  The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.

Authors:  Alex T Raben; Victoria S Marshe; Araba Chintoh; Ilona Gorbovskaya; Daniel J Müller; Margaret K Hahn
Journal:  Front Neurosci       Date:  2018-01-22       Impact factor: 4.677

4.  Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre.

Authors:  Ilaria Tarricone; Michela Casoria; Beatrice Ferrari Gozzi; Daniela Grieco; Marco Menchetti; Alessandro Serretti; Manjola Ujkaj; Francesca Pastorelli; Domenico Berardi
Journal:  BMC Psychiatry       Date:  2006-03-16       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.